{"id":"NCT01606137","sponsor":"Jazz Pharmaceuticals","briefTitle":"A Study of the Long-term Safety of Sativex Use","officialTitle":"A Long-term, Open Label, Safety and Tolerability Study of Cannabis Based Medicine Extract in Patients Who Have Participated in a GW Clinical Study Using Cannabis Based Medicine.","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2002-02","primaryCompletion":"2004-12","completion":"2004-12","firstPosted":"2012-05-25","resultsPosted":"2012-08-23","lastUpdate":"2023-05-06"},"enrollment":507,"design":{"allocation":"NA","model":"SINGLE_GROUP","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["Multiple Sclerosis","Spasticity","Pain"],"interventions":[{"type":"DRUG","name":"GW-1000-02","otherNames":["Sativex"]}],"arms":[{"label":"GW-1000-02","type":"EXPERIMENTAL"}],"summary":"Subjects who had previously received GW-1000-02 in a GW study who opted to continue using it in the long-term were monitored for ongoing tolerability and evidence of clinical benefit.","primaryOutcome":{"measure":"Incidence of Adverse Events as a Measure of Subject Safety.","timeFrame":"Up to 1051 days","effectByArm":[{"arm":"GW-1000-02","deltaMin":477,"sd":null}],"pValues":[]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":12,"exclusionCount":13},"locations":{"siteCount":1,"countries":["United Kingdom"]},"refs":{"pmids":["22878432"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":74,"n":507},"commonTop":["Dizziness","Urinary Tract Infection NOS","Nausea","Fatigue","Diarrhoea NOS"]}}